Header Logo

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies.

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies. Cancers (Basel). 2023 May 09; 15(10).

View in: PubMed

© 2025 Kaiser Permanente